Skip to content
★ Sign in to follow
BE

Bruce Eaton

Vice-Président Exécutif, Responsable Commercial
Editas Medicine, Inc.
Total declarations
26
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (23 ops.)
€141k

Latest filing published 07 Dec 2023 for Editas Medicine, Inc., €1,036.

Filing timeline

BuySale
Bruce Eaton

Insider track record

Disclosed buys
0
Disclosed sells
23

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Bruce Eaton: trading record in brief

Bruce Eaton, listed as senior executive, appears in our data through filings on Editas Medicine, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 9 August 2021 to 5 December 2023, the count stands at 26 filings.

The open-market record consists of 23 sales worth €141k, with no purchase. Other entries cover 3 share grants. Since January 2023: no purchases and 12 sales on the market.

On 7 December 2023 came the latest disclosure, an open-market sale for €1,036 in Editas Medicine, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Bruce Eaton

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations24 total
  • ▼
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    1,122 USD9SEC
    103 shares@ US$10.89720.8% of flowCommon StockSEC:0001650664-23-000029:0
  • ▼
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    5,706 USD9SEC
    695 shares@ US$8.20964.0% of flowCommon StockSEC:0001650664-23-000022:0
  • ▼
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    1,168 USD9SEC
    139 shares@ US$8.400.8% of flowCommon StockSEC:0001650664-23-000019:0
  • ▼
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    908 USD9SEC
    103 shares@ US$8.820.6% of flowCommon StockSEC:0001650664-23-000002:0
  • ▼
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    6,033 USD21SEC
    702 shares@ US$8.59354.1% of flowCommon StockSEC:0001415889-23-012264:0
  • ▼
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    1,183 USD21SEC
    141 shares@ US$8.390.8% of flowCommon StockSEC:0001415889-23-012049:0
  • ▼
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    998 USD24SEC
    105 shares@ US$9.5030.7% of flowCommon StockSEC:0001415889-23-009368:0
  • ▼
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    6,595 USD24SEC
    668 shares@ US$9.8724.5% of flowCommon StockSEC:0001415889-23-007989:0
  • ▼
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    1,284 USD24SEC
    135 shares@ US$9.510.9% of flowCommon StockSEC:0001415889-23-007816:0
  • ◆
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    0SEC
    16,700 shares0Common StockSEC:0001415889-23-004312:0
  • ▼
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    31,963 USD26SEC
    3,307 shares@ US$9.665322.5% of flowCommon StockSEC:0001415889-23-002602:0
  • ▼
    EVP, CBO AND CTOExecutivesEditas Medicine, Inc.
    3,841 USD24SEC
    346 shares@ US$11.102.7% of flowCommon StockSEC:0001415889-23-002218:0
  • ▼
    EVP, CHIEF BUSINESS OFFICERExecutivesEditas Medicine, Inc.
    1,043 USD21SEC
    102 shares@ US$10.230.7% of flowCommon StockSEC:0001415889-22-012131:0
  • ▼
    EVP, CHIEF BUSINESS OFFICERExecutivesEditas Medicine, Inc.
    3,185 USD21SEC
    289 shares@ US$11.022.4% of flowCommon StockSEC:0001415889-22-011242:0
  • ▼
    EVP, CHIEF BUSINESS OFFICERExecutivesEditas Medicine, Inc.
    1,516 USD21SEC
    101 shares@ US$15.011.2% of flowCommon StockSEC:0001415889-22-009448:0
  • ▼
    EVP, CHIEF BUSINESS OFFICERExecutivesEditas Medicine, Inc.
    5,449 USD21SEC
    293 shares@ US$18.59864.0% of flowCommon StockSEC:0001415889-22-008463:0
  • ▼
    EVP, CHIEF BUSINESS OFFICERExecutivesEditas Medicine, Inc.
    12,956 USD24SEC
    1,123 shares@ US$11.536910.2% of flowCommon StockSEC:0001415889-22-006162:0
  • ▼
    EVP, CHIEF BUSINESS OFFICERExecutivesEditas Medicine, Inc.
    3,895 USD11SEC
    297 shares@ US$13.11283.1% of flowCommon StockSEC:0001415889-22-004837:0
  • ▼
    EVP, CHIEF BUSINESS OFFICERExecutivesEditas Medicine, Inc.
    16,408 USD12SEC
    287 shares@ US$57.1711.8% of flowCommon StockSEC:0001415889-22-003709:0
  • ▼
    EVP, CHIEF BUSINESS OFFICERExecutivesEditas Medicine, Inc.
    6,983 USD24SEC
    403 shares@ US$17.32775.3% of flowCommon StockSEC:0001415889-22-002656:0
  • ◆
    EVP, CHIEF BUSINESS OFFICERExecutivesEditas Medicine, Inc.
    0SEC
    37,593 shares0Common StockSEC:0001415889-22-001225:0
  • ▼
    EVP, CHIEF BUSINESS OFFICERExecutivesEditas Medicine, Inc.
    5,323 USD23SEC
    302 shares@ US$17.62613.9% of flowCommon StockSEC:0001415889-22-001195:0
  • ◆
    EVP, Chief Business OfficerExecutivesEditas Medicine, Inc.
    0SEC
    3,472 shares0Common StockSEC:0001179110-21-011227:0
  • ▼
    EVP, Chief Business OfficerExecutivesEditas Medicine, Inc.
    11,655 USD24SEC
    287 shares@ US$40.618.5% of flowCommon StockSEC:0001179110-21-010059:0

24 of 24 declarations